Zhang Haiwen, Solomon V Raja, Hu Changkun, Ulibarri Gerardo, Lee Hoyun
Tumour Biology Group, Northeastern Ontario Regional Cancer Program at the Sudbury Regional Hospital, 41 Ramsey Lake Road, Sudbury, Ontario P3E 5J1, Canada.
Biomed Pharmacother. 2008 Feb;62(2):65-9. doi: 10.1016/j.biopha.2007.04.007. Epub 2007 May 24.
A series of 4-aminoquinoline derivatives were synthesized by the reaction of 4-chloro-7-substituted-quinolines with the corresponding mono/dialkyl amines. The structures of the synthesized compounds were confirmed by NMR and FAB-MS spectral and elemental analyses. Subsequently, the compounds were examined for their cytotoxic effects on two different human breast tumor cell lines: MCF7 and MDA-MB468. Although all compounds examined were quite effective on both cell lines, the compound N'-(7-chloro-quinolin-4-yl)-N,N-dimethyl-ethane-1,2-diamine emerged as the most active compound of the series. It was particularly potent against MDA-MB 468 cells when compared to chloroquine and amodiaquine. The compound butyl-(7-fluoro-quinolin-4-yl)-amine showed more potent effects on MCF-7 cells when compared to chloroquine. Therefore, 4-aminoquinoline can serve as the prototype molecule for further development of a new class of anticancer agents.
通过4-氯-7-取代喹啉与相应的单/二烷基胺反应合成了一系列4-氨基喹啉衍生物。通过核磁共振(NMR)、快原子轰击质谱(FAB-MS)光谱和元素分析确定了合成化合物的结构。随后,研究了这些化合物对两种不同人类乳腺肿瘤细胞系MCF7和MDA-MB468的细胞毒性作用。尽管所检测的所有化合物对这两种细胞系都相当有效,但化合物N'-(7-氯喹啉-4-基)-N,N-二甲基乙烷-1,2-二胺成为该系列中最具活性的化合物。与氯喹和阿莫地喹相比,它对MDA-MB 468细胞特别有效。与氯喹相比,化合物丁基-(7-氟喹啉-4-基)-胺对MCF-7细胞显示出更强的作用。因此,4-氨基喹啉可作为进一步开发新型抗癌药物的原型分子。